Katie Tuckwell

Katie Tuckwell currently serves as the Director of Regeneron Genetic Medicines at Regeneron since October 2022. Previously, Katie held the position of Senior Director of Clinical Development at Sonoma Biotherapeutics from May 2021 to October 2022. Katie's extensive experience includes roles at Genentech as a Principal Clinical Scientist and Senior Clinical Scientist, and at Roche in various capacities from Clinical Development Scientist to Biosample Operations Manager. Early career experiences include positions at the University of Cambridge as a Research Associate and at DNA Electronics as a Molecular Biologist. Katie began their professional journey in project management and medical writing with TVF Communications and Photosound, respectively. Educational qualifications include a PhD in Biochemistry from the University of Bristol and a Bachelor of Science in Biochemistry from the University of Reading.